Literature DB >> 16608946

Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?

Tony Dremsizov1, Gilles Clermont, John A Kellum, Kenneth G Kalassian, Michael J Fine, Derek C Angus.   

Abstract

STUDY
OBJECTIVES: Most natural history studies of severe sepsis are limited to ICU populations. We describe the onset and timing of severe sepsis during the hospital course for patients hospitalized with community-acquired pneumonia (CAP). We also determine the ability of the systemic inflammatory response syndrome (SIRS) and other proposed risk stratification scores measured at emergency department (ED) presentation to predict progression to severe sepsis, septic shock, or death.
DESIGN: Retrospective analysis of a prospective observational outcome study from the Pneumonia Patient Outcomes Research Team (PORT).
SETTING: Four academic medical centers in the United States and Canada between October 1991 and March 1994. PARTICIPANTS: The 1,339 patients hospitalized for CAP in the PORT study cohort, and a random subset of 686 patients for whom we had information for SIRS criteria.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: All subjects had infection (CAP). Severe sepsis was defined as new-onset acute organ dysfunction in this cohort, using consensus criteria. Severe sepsis developed in one half of the patients (n = 639, 48%), nonpulmonary organ dysfunction developed in 520 patients (39%), and septic shock developed in 61 subjects (4.5%). Severe sepsis and septic shock were present at ED presentation in 457 patients (71% of severe sepsis cases) and 27 patients (44% of septic shock cases), respectively. While SIRS was common at presentation (82% of the subset of 686 had two SIRS criteria), it was not associated with increased odds for progression to severe sepsis (odds ratios [ORs], 0.65 and 0.89 for two or more SIRS criteria and three or more SIRS criteria, respectively), septic shock (ORs, 0.80 and 0.55), or death (ORs, 0.65 and 0.39), with poor discrimination (all receiver operating characteristic [ROC] areas under the curve < 0.5). The pneumonia severity index was associated with severe sepsis (p < 0.001) with moderate discrimination (ROC, 0.63).
CONCLUSIONS: Severe sepsis is common in hospitalized CAP patients, occurring early in the hospital course. SIRS criteria do not appear to be useful predictors for progression to severe sepsis in CAP.

Entities:  

Mesh:

Year:  2006        PMID: 16608946     DOI: 10.1378/chest.129.4.968

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  45 in total

Review 1.  Towards a sensible comprehension of severe community-acquired pneumonia.

Authors:  Santiago Ewig; Mark Woodhead; Antoni Torres
Journal:  Intensive Care Med       Date:  2010-11-16       Impact factor: 17.440

2.  Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapies.

Authors:  H Lode
Journal:  Intensive Care Med       Date:  2008-12-10       Impact factor: 17.440

3.  Comparative study of the prevalence of sepsis in patients admitted to dermatology and internal medicine wards.

Authors:  Luiz Maurício Costa Almeida; Michelle dos Santos Diniz; Lorena dos Santos Diniz; Jackson Machado-Pinto; Francisco Chagas Lima Silva
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

4.  Community-Acquired Pneumonia in Adults.

Authors:  Martin Kolditz; Santiago Ewig
Journal:  Dtsch Arztebl Int       Date:  2017-12-08       Impact factor: 5.594

5.  Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia.

Authors:  Wesley H Self; Carlos G Grijalva; Derek J Williams; Alison Woodworth; Robert A Balk; Sherene Fakhran; Yuwei Zhu; D Mark Courtney; James Chappell; Evan J Anderson; Chao Qi; Grant W Waterer; Christopher Trabue; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2016-04-21       Impact factor: 9.410

6.  Managing CAP in the ICU.

Authors:  Liapikou Adamantia; Makrodimitri Sotiria; Melaxroinidou Myrsini; Toumbis Michael
Journal:  Curr Infect Dis Rep       Date:  2015-11       Impact factor: 3.725

7.  Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment.

Authors:  Graciela Andonegui; Erin L Zelinski; Courtney L Schubert; Derrice Knight; Laura A Craig; Brent W Winston; Simon C Spanswick; Björn Petri; Craig N Jenne; Janice C Sutherland; Rita Nguyen; Natalie Jayawardena; Margaret M Kelly; Christopher J Doig; Robert J Sutherland; Paul Kubes
Journal:  JCI Insight       Date:  2018-05-03

8.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.

Authors:  I Martin-Loeches; T Lisboa; A Rodriguez; C Putensen; D Annane; J Garnacho-Montero; M I Restrepo; J Rello
Journal:  Intensive Care Med       Date:  2009-12-02       Impact factor: 17.440

9.  T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.

Authors:  R V Anantha; D M Mazzuca; S X Xu; S A Porcelli; D D Fraser; C M Martin; I Welch; T Mele; S M M Haeryfar; J K McCormick
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

10.  The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study.

Authors:  Pål Comstedt; Merete Storgaard; Annmarie T Lassen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-12-27       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.